Healthcare provider profile · identity verified

Rod M Duraski, MD

Internal Medicine · LAGRANGE, GA · NPI 1649363300

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	613	167
Amlodipine Besylate	Amlodipine Besylate	560	147
Losartan Potassium	Losartan Potassium	367	106
Levothyroxine Sodium	Levothyroxine Sodium	335	87
Hydrochlorothiazide	Hydrochlorothiazide	252	68
Lisinopril	Lisinopril	251	68
Metformin Hcl	Metformin Hcl	233	62
Omeprazole	Omeprazole	217	56
Furosemide	Furosemide	194	60
Pravastatin Sodium	Pravastatin Sodium	193	58
Rosuvastatin Calcium	Rosuvastatin Calcium	176	55
Simvastatin	Simvastatin	176	45
Metoprolol Succinate	Metoprolol Succinate	174	43
Potassium Chloride	Potassium Chloride	152	38
Nifedipine Er	Nifedipine	146	36
Eliquis	Apixaban	141	30
Alendronate Sodium	Alendronate Sodium	138	32
Gabapentin	Gabapentin	136	45
Metoprolol Tartrate	Metoprolol Tartrate	132	31
Tamsulosin Hcl	Tamsulosin Hcl	115	30
Metformin Hcl Er	Metformin Hcl	112	41
Albuterol Sulfate Hfa	Albuterol Sulfate	111	32
Pantoprazole Sodium	Pantoprazole Sodium	111	29
Hydralazine Hcl	Hydralazine Hcl	109	26
Atenolol	Atenolol	106	29
Alprazolam	Alprazolam	99	16
Carvedilol	Carvedilol	99	28
Ozempic	Semaglutide	97	17
Glimepiride	Glimepiride	96	23
Jardiance	Empagliflozin	95	21
Montelukast Sodium	Montelukast Sodium	94	21
Famotidine	Famotidine	93	25
Ezetimibe	Ezetimibe	90	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	90	19
Clonidine Hcl	Clonidine Hcl	79	21
Allopurinol	Allopurinol	77	24
Fluoxetine Hcl	Fluoxetine Hcl	69	19
Januvia	Sitagliptin Phosphate	66	12
Meclizine Hcl	Meclizine Hcl	61	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	60	suppressed
Clopidogrel	Clopidogrel Bisulfate	59	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	58	17
Paroxetine Hcl	Paroxetine Hcl	57	13
Valsartan	Valsartan	54	15
Duloxetine Hcl	Duloxetine Hcl	52	13
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	51	51
Cephalexin	Cephalexin	48	40
Sertraline Hcl	Sertraline Hcl	46	13
Methylprednisolone	Methylprednisolone	45	40
Trazodone Hcl	Trazodone Hcl	44	14
Meloxicam	Meloxicam	43	15
Chlorthalidone	Chlorthalidone	42	13
Doxycycline Hyclate	Doxycycline Hyclate	41	35
Bupropion Hcl Sr	Bupropion Hcl	40	suppressed
Glipizide	Glipizide	37	suppressed
Glipizide Er	Glipizide	36	11
Lovastatin	Lovastatin	36	11
Lorazepam	Lorazepam	34	suppressed
Mounjaro	Tirzepatide	33	suppressed
Buspirone Hcl	Buspirone Hcl	32	suppressed
Fluticasone Propionate	Fluticasone Propionate	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Synthroid	Levothyroxine Sodium	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Clonazepam	Clonazepam	30	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	30	23
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Finasteride	Finasteride	29	suppressed
Levetiracetam	Levetiracetam	28	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	28	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Prednisone	Prednisone	26	15
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Tramadol Hcl	Tramadol Hcl	25	suppressed
Carbamazepine	Carbamazepine	24	suppressed
Clotrimazole	Clotrimazole	23	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	11
Amoxicillin	Amoxicillin	21	20
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Estradiol	Estradiol	21	suppressed
Linzess	Linaclotide	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Nitroglycerin	Nitroglycerin	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	11
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	18	18
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Nystatin	Nystatin	17	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Humulin N	Insulin Nph Human Isophane	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Raloxifene Hcl	Raloxifene Hcl	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Naproxen	Naproxen	14	11
Telmisartan	Telmisartan	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	12
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Ramipril	Ramipril	13	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Ciloxan	Ciprofloxacin Hcl	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error